Debruyne, David N.
Dries, Ruben
Sengupta, Satyaki
Seruggia, Davide
Gao, Yang
Sharma, Bandana
Huang, Hao
Moreau, Lisa
McLane, Michael
Day, Daniel S.
Marco, Eugenio
Chen, Ting
Gray, Nathanael S.
Wong, Kwok-Kin
Orkin, Stuart H.
Yuan, Guo-Cheng
Young, Richard A.
George, Rani E.
Article History
Received: 21 July 2017
Accepted: 11 July 2019
First Online: 7 August 2019
Competing interests
: N.S.G. is a founder, SAB member and equity holder of Gatekeeper, Syros Pharmaceuticals, Petra, C4, B2S and Soltego. The Gray laboratory receives or has received research funding from Novartis, Takeda, Astellas, Taiho, Janssen, Kinogen, Voronoi, Her2llc, Deerfield and Sanofi. S.H.O. is a SAB member of Syros. R.A.Y. is a founder and shareholder of Syros, Camp4 Therapeutics, Omega Therapeutics and Dewpoint Therapeutics. R.E.G. is a SAB member of Global Gene Corp.